| IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy V Suppiah, M Moldovan, G Ahlenstiel, T Berg, M Weltman, ML Abate, ... Nature genetics 41 (10), 1100, 2009 | 2093 | 2009 |
| Natural killer cells are polarized toward cytotoxicity in chronic hepatitis C in an interferon-alfa–dependent manner G Ahlenstiel, RH Titerence, C Koh, B Edlich, JJ Feld, Y Rotman, ... Gastroenterology 138 (1), 325-335. e2, 2010 | 250 | 2010 |
| Surface expression and cytolytic function of natural killer cell receptors is altered in chronic hepatitis C J Nattermann, G Feldmann, G Ahlenstiel, B Langhans, T Sauerbruch, ... Gut 55 (6), 869-877, 2006 | 244 | 2006 |
| The HLA-A2 restricted T cell epitope HCV core35–44 stabilizes HLA-E expression and inhibits cytolysis mediated by natural killer cells J Nattermann, HD Nischalke, V Hofmeister, G Ahlenstiel, H Zimmermann, ... The American journal of pathology 166 (2), 443-453, 2005 | 170 | 2005 |
| Distinct KIR/HLA compound genotypes affect the kinetics of human antiviral natural killer cell responses G Ahlenstiel, MP Martin, X Gao, M Carrington, B Rehermann The Journal of clinical investigation 118 (3), 1017-1026, 2008 | 167 | 2008 |
| Early changes in natural killer cell function indicate virologic response to interferon therapy for hepatitis C G Ahlenstiel, B Edlich, LJ Hogdal, Y Rotman, M Noureddin, JJ Feld, ... Gastroenterology 141 (4), 1231-1239. e2, 2011 | 149 | 2011 |
| Frequency of the HIV-protective CC chemokine receptor 5-Δ32/Δ32 genotype is increased in hepatitis C RP Woitas, G Ahlenstiel, A Iwan, JK Rockstroh, HH Brackmann, B Kupfer, ... Gastroenterology 122 (7), 1721-1728, 2002 | 140 | 2002 |
| HIV-1 infection leads to increased HLA-E expression resulting in impaired function of natural killer cells J Nattermann, HD Nischalke, V Hofmeister, B Kupfer, G Ahlenstiel, ... Antivir Ther 10 (1), 95-107, 2005 | 131 | 2005 |
| Natural killer cell function is intact after direct exposure to infectious hepatitis C virions JC Yoon, M Shiina, G Ahlenstiel, B Rehermann Hepatology 49 (1), 12-21, 2009 | 124 | 2009 |
| IL28B, HLA-C, and KIR variants additively predict response to therapy in chronic hepatitis C virus infection in a European Cohort: a cross-sectional study V Suppiah, S Gaudieri, NJ Armstrong, KS O'Connor, T Berg, M Weltman, ... PLoS medicine 8 (9), e1001092, 2011 | 113 | 2011 |
| Early changes in interferon signaling define natural killer cell response and refractoriness to interferon‐based therapy of hepatitis C patients B Edlich, G Ahlenstiel, AA Zabaleta, J Stoltzfus, M Noureddin, E Serti, ... Hepatology 55 (1), 39-48, 2012 | 103 | 2012 |
| Interferon-λ rs12979860 genotype and liver fibrosis in viral and non-viral chronic liver disease M Eslam, AM Hashem, R Leung, M Romero-Gomez, T Berg, GJ Dore, ... Nature communications 6, 6422, 2015 | 91 | 2015 |
| Influence of interleukin 12B (IL12B) polymorphisms on spontaneous and treatment-induced recovery from hepatitis C virus infection T Mueller, A Mas-Marques, C Sarrazin, M Wiese, J Halangk, H Witt, ... Journal of hepatology 41 (4), 652-658, 2004 | 83 | 2004 |
| Actual endoscopic versus predicted surgical mortality for treatment of advanced mucosal neoplasia of the colon G Ahlenstiel, LF Hourigan, G Brown, S Zanati, SJ Williams, R Singh, ... Gastrointestinal endoscopy 80 (4), 668-676, 2014 | 80 | 2014 |
| Identification of improved IL28B SNPs and haplotypes for prediction of drug response in treatment of hepatitis C using massively parallel sequencing in a cross-sectional … KR Smith, V Suppiah, K O'Connor, T Berg, M Weltman, ML Abate, ... Genome medicine 3 (8), 57, 2011 | 67 | 2011 |
| S-adenosyl methionine improves early viral responses and interferon-stimulated gene induction in hepatitis C nonresponders JJ Feld, AA Modi, R El–Diwany, Y Rotman, E Thomas, G Ahlenstiel, ... Gastroenterology 140 (3), 830-839. e3, 2011 | 63 | 2011 |
| Binding of HCV E2 to CD81 induces RANTES secretion and internalization of CC chemokine receptor 5 J Nattermann, HD Nischalke, G Feldmann, G Ahlenstiel, T Sauerbruch, ... Journal of viral hepatitis 11 (6), 519-526, 2004 | 62 | 2004 |
| IL28B in hepatitis C virus infection: translating pharmacogenomics into clinical practice G Ahlenstiel, DR Booth, J George Journal of Gastroenterology 45 (9), 903-910, 2010 | 61 | 2010 |
| Effect of ribavirin on viral kinetics and liver gene expression in chronic hepatitis C Y Rotman, M Noureddin, JJ Feld, J Guedj, M Witthaus, H Han, YJ Park, ... Gut 63 (1), 161-169, 2014 | 57 | 2014 |
| Effects of the CCR5-Δ32 mutation on antiviral treatment in chronic hepatitis C G Ahlenstiel, T Berg, RP Woitas, F Grünhage, A Iwan, L Heß, ... Journal of hepatology 39 (2), 245-252, 2003 | 45 | 2003 |
Tilman SauerbruchProfessor emeritusVerified email at uni-bonn.de